Development of Innovative Method of Steel Surface Hardening by a Combined Chemical-thermal Treatment

The aim of the article is a hardening of the surface steel layers due to the combination treatment. Samples of steel 38Cr2MoAl were hardened by complex chemical and thermal treatment such as carburizing and subsequent boriding. It was established that surface double-layer hardening for steel 38Cr2MoAl with sequential saturation with atomic carbon (during carburizing) and atomic boron (during furnace boriding) at different temperatures allowed to form a boride layer with transition zone.The obtaining transition zone can improve operational properties of machine parts and tools by micro-friability reduction of diffusion layer. An optimal mode of complex chemical-thermal treatment (CTT) was obtained for the regime, which includes carburizing at 950 °C for 2 hours, boriding at 950 °C for 2 hours, which allows to get the best value for the surface hardness of 22 GPa with a maximum overall diffusion layer 1.4 mm. Due to the technology of combined treatment we can significantly reduce treatment time compared to traditional hardening means and significantly improve product performance properties due to the transition zone between the borides and the matrix of machine elements. The technology can be used in enterprises where there is any hardening furnace without additional installation or conversion of equipment

SURFACE HARDENING OF AUTOMOBILES AND TRACTORS PARTS BY METHOD OF LOW-TEMPERATURE CARBONITRIDING IN POWDER MEDIUM

Performed is strengthening of the surface layer of steel method of low-temperature carbonitriding in macrodispersed carbo - and nitrogen-bearing powder mixture. Chosen and justified the optimal technological parameters of process developed chemical-thermal processing. The diffusion coefficient of nitrogen alloyed steel 40X for the proposed treatment

Simulation of Diffusion Processes in Chemical and Thermal Processing of Machine Parts

To solve a number of technological issues, it is advisable to use mathematical modeling, which will allow us to obtain the dependences of the influence of the technological parameters of chemical and thermal treatment processes on forming the depth of the diffusion layers of steels and alloys. The paper presents mathematical modeling of diffusion processes based on the existing chemical and thermal treatment of steel parts. Mathematical modeling is considered on the example of 38Cr2MoAl steel after gas nitriding. The gas nitriding technology was carried out at different temperatures for a duration of 20, 50, and 80 h in the SSHAM-12.12/7 electric furnace. When modeling the diffusion processes of surface hardening of parts in general, providing a specifically given distribution of nitrogen concentration over the diffusion layer’s depth from the product’s surface was solved. The model of the diffusion stage is used under the following assumptions: The diffusion coefficient of the saturating element primarily depends on temperature changes; the metal surface is instantly saturated to equilibrium concentrations with the saturating atmosphere; the surface layer and the entire product are heated unevenly, that is, the product temperature is a function of time and coordinates. Having satisfied the limit, initial, and boundary conditions, the temperature distribution equations over the diffusion layer’s depth were obtained. The final determination of the temperature was solved by an iterative method. Mathematical modeling allowed us to get functional dependencies for calculating the temperature distribution over the depth of the layer and studying the influence of various factors on the body’s temperature state of the body

Impact of Magnetic-Pulse and Chemical-Thermal Treatment on Alloyed Steels’ Surface Layer

The relevant problem is searching for up-to-date methods to improve tools and machine parts’ performance due to the hardening of surface layers. This article shows that, after the magnetic-pulse treatment of bearing steel Cr15, its surface microhardness was increased by 40–50% compared to baseline. In this case, the depth of the hardened layer was 0.08–0.1 mm. The magnetic-pulse processing of hard alloys reduces the coefficient of microhardness variation from 0.13 to 0.06. A decrease in the coefficient of variation of wear resistance from 0.48 to 0.27 indicates the increased stability of physical and mechanical properties. The nitriding of alloy steels was accelerated 10-fold that of traditional gas upon receipt of the hardened layer depth of 0.3–0.5 mm. As a result, the surface hardness was increased to 12.7 GPa. Boriding in the nano-dispersed powder was accelerated 2–3-fold compared to existing technologies while ensuring surface hardness up to 21–23 GPa with a boride layer thickness of up to 0.073 mm. Experimental data showed that the cutting tool equipped with inserts from WC92Co8 and WC79TiC15 has a resistance relative to the untreated WC92Co8 higher by 183% and WC85TiC6Co9—than 200%. Depending on alloy steel, nitriding allowed us to raise wear resistance by 120–177%, boriding—by 180–340%, and magneto-pulse treatment—by more than 183–200%

Oxygen-induced retinopathy in the mouse.

PURPOSE: To develop oxygen-induced retinopathy in the mouse with reproducible and quantifiable proliferative retinal neovascularization suitable for examining pathogenesis and therapeutic intervention for retinal neovascularization in retinopathy of prematurity (ROP) and other vasculopathologies. METHODS: One-week-old C57BL/6J mice were exposed to 75% oxygen for 5 days and then to room air. A novel fluorescein-dextran perfusion method has been developed to assess the vascular pattern. The proliferative neovascular response was quantified by counting the nuclei of new vessels extending from the retina into the vitreous in 6 microns sagittal cross-sections. Cross-sections were also stained for glial fibrillary acidic protein (GFAP). RESULTS: Fluorescein-dextran angiography delineated the entire vascular pattern, including neovascular tufts in flat-mounted retinas. Hyperoxia-induced neovascularization occurred at the junction between the vascularized and avascular retina in the mid-periphery. Retinal neovascularization occurred in all the pups between postnatal day 17 and postnatal day 21. There was a mean of 89 neovascular nuclei per cross-section of 9 eyes in hyperoxia compared to less than 1 nucleus per cross-section of 8 eyes in the normoxia control (P < 0.0001). Proliferative vessels were not associated with GFAP-positive astrocyte processes. CONCLUSIONS: The authors have described a reproducible and quantifiable mouse model of oxygen-induced retinal neovascularization that should prove useful for the study of pathogenesis of retinal neovascularization as well as for the study of medical intervention for ROP and other retinal angiopathies

The Impact of Different Types of Assistive Devices on Gait Measures and Safety in Huntington's Disease

BACKGROUND: Gait and balance impairments lead to frequent falls and injuries in individuals with Huntington's disease (HD). Assistive devices (ADs) such as canes and walkers are often prescribed to prevent falls, but their efficacy is unknown. We systematically examined the effects of different types of ADs on quantitative gait measures during walking in a straight path and around obstacles. METHODS: Spatial and temporal gait parameters were measured in 21 subjects with HD as they walked across a GAITRite walkway under 7 conditions (i.e., using no AD and 6 commonly prescribed ADs: a cane, a weighted cane, a standard walker, and a 2, 3 or 4 wheeled walker). Subjects also were timed and observed for number of stumbles and falls while walking around two obstacles in a figure-of-eight pattern. RESULTS: Gait measure variability (i.e., coefficient of variation), an indicator of fall risk, was consistently better when using the 4WW compared to other ADs. Subjects also walked the fastest and had the fewest number of stumbles and falls when using the 4WW in the figure-of-eight course. Subjects walked significantly slower using ADs compared to no AD both across the GAITRite and in the figure-of-eight. Measures reflecting gait stability and safety improved with the 4WW but were made worse by some other ADs

Magnetic interactions in EuTe epitaxial layers and EuTe/PbTe superlattices

The magnetic properties of antiferromagnetic (AFM) EuTe epitaxial layers and short period EuTe/PbTe superlattices (SLs), grown by molecular beam epitaxy on (111) BaF$_2$ substrates, were studied by magnetization and neutron diffraction measurements. Considerable changes of the N\'eel temperature as a function of the EuTe layer thickness as well as of the strain state were found. A mean field model, taking into account the variation of the exchange constants with the strain-induced lattice distortions, and the nearest neighbor environment of a Eu atoms, was developed to explain the observed $T_{\text N}$ changes in wide range of samples. Pronounced interlayer magnetic correlations have been revealed by neutron diffraction in EuTe/PbTe SLs with PbTe spacer thickness up to 60 \AA. The observed diffraction spectra were analyzed, in a kinematical approximation, assuming partial interlayer correlations characterized by an appropriate correlation parameter. The formation of interlayer correlations between the AFM EuTe layers across the nonmagnetic PbTe spacer was explained within a framework of a tight-binding model. In this model, the interlayer coupling stems from the dependence of the total electronic energy of the EuTe/PbTe SL on the spin configurations in adjacent EuTe layers. The influence of the EuTe and PbTe layer thickness fluctuations, inherent in the epitaxial growth process, on magnetic properties and interlayer coupling is discussed.Comment: 17 pages, 19 figures, accepted to PR

A computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer's as a case study

Abstract Background A molecular characterization of Alzheimer's Disease (AD) is the key to the identification of altered gene sets that lead to AD progression. We rely on the assumption that candidate marker genes for a given disease belong to specific pathogenic pathways, and we aim at unveiling those pathways stable across tissues, treatments and measurement systems. In this context, we analyzed three heterogeneous datasets, two microarray gene expression sets and one protein abundance set, applying a recently proposed feature selection method based on regularization. Results For each dataset we identified a signature that was successively evaluated both from the computational and functional characterization viewpoints, estimating the classification error and retrieving the most relevant biological knowledge from different repositories. Each signature includes genes already known to be related to AD and genes that are likely to be involved in the pathogenesis or in the disease progression. The integrated analysis revealed a meaningful overlap at the functional level. Conclusions The identification of three gene signatures showing a relevant overlap of pathways and ontologies, increases the likelihood of finding potential marker genes for AD.</p

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington\u27s Disease Patients-A Randomized Phase 2 Clinical Trial.

SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP on aggression/fear circuits in an experimental medicine fMRI study and demonstrated excellent safety in Phase 1 multiple-ascending dose clinical trials. The present study was a 3-arm, multicenter, randomized, placebo-controlled, double-blind, 12-week, dose escalation study of SRX246 in early symptomatic Huntington\u27s disease (HD) patients with irritability. Our goal was to determine whether SRX246 was safe and well tolerated in these HD patients given its potential use for the treatment of problematic neuropsychiatric symptoms. Participants were randomized to receive placebo or to escalate to 120 mg twice daily or 160 mg twice daily doses of SRX246. Assessments included standard safety tests, the Unified Huntington\u27s Disease Rating Scale (UHDRS), and exploratory measures of problem behaviors. The groups had comparable demographics, features of HD and baseline irritability. Eighty-two out of 106 subjects randomized completed the trial on their assigned dose of drug. One-sided exact-method confidence interval tests were used to reject the null hypothesis of inferior tolerability or safety for each dose group vs. placebo. Apathy and suicidality were not affected by SRX246. Most adverse events in the active arms were considered unlikely to be related to SRX246. The compound was safe and well tolerated in HD patients and can be moved forward as a candidate to treat irritability and aggression